CR9483A - Sistema terapeutico transdermico solido con absorbedor uv - Google Patents

Sistema terapeutico transdermico solido con absorbedor uv

Info

Publication number
CR9483A
CR9483A CR9483A CR9483A CR9483A CR 9483 A CR9483 A CR 9483A CR 9483 A CR9483 A CR 9483A CR 9483 A CR9483 A CR 9483A CR 9483 A CR9483 A CR 9483A
Authority
CR
Costa Rica
Prior art keywords
therapeutic system
transdermal therapeutic
absorber
solid transdermal
active substance
Prior art date
Application number
CR9483A
Other languages
English (en)
Inventor
Langguth Thomas
Bracht Stefan
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CR9483A publication Critical patent/CR9483A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invencion se refiere a un nuevo sistema terapeutico transdermico solido con absorbedor uv disenado especialmente para sustancias activas farmaceuticas sensible a la luz. El sitema terapeutico transdermico ( STT) estable a los rayos UV comprende una capa de base , al menos una matriz que contiene sustancia activa y una pelicula protectora desprendible donde opcionalmente se puede intercalar una capa adhesiva y una capa separadora entre la capa base y la matriz que contiene sustancia activa.
CR9483A 2005-05-02 2007-10-30 Sistema terapeutico transdermico solido con absorbedor uv CR9483A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05009579A EP1719504A1 (de) 2005-05-02 2005-05-02 Festes transdermales therapeutisches System mit UV-Absorber

Publications (1)

Publication Number Publication Date
CR9483A true CR9483A (es) 2008-01-21

Family

ID=34981458

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9483A CR9483A (es) 2005-05-02 2007-10-30 Sistema terapeutico transdermico solido con absorbedor uv

Country Status (26)

Country Link
EP (2) EP1719504A1 (es)
JP (2) JP5360877B2 (es)
KR (2) KR101426218B1 (es)
CN (2) CN108969507A (es)
AR (1) AR055927A1 (es)
AU (1) AU2006243442A1 (es)
BR (1) BRPI0611087A2 (es)
CA (1) CA2605112C (es)
CR (1) CR9483A (es)
CY (1) CY1115757T1 (es)
DK (1) DK1879560T3 (es)
DO (1) DOP2006000100A (es)
EA (1) EA200702344A1 (es)
ES (1) ES2523663T3 (es)
GT (1) GT200600183A (es)
IL (1) IL186945A0 (es)
MX (1) MX2007013779A (es)
NO (1) NO20076187L (es)
PE (1) PE20061414A1 (es)
PL (1) PL1879560T3 (es)
PT (1) PT1879560E (es)
SI (1) SI1879560T1 (es)
TW (1) TW200719902A (es)
UY (1) UY29511A1 (es)
WO (1) WO2006117139A2 (es)
ZA (1) ZA200710418B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ541807A (en) 2003-02-21 2009-07-31 Bayer Schering Pharma Ag UV stable transdermal therapeutic plaster
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
WO2012031999A2 (en) 2010-09-06 2012-03-15 Bayer Pharma Aktiengesellschaft Low-dose transdermal patches with high drug release

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
DE59107052D1 (de) * 1990-03-30 1996-01-25 Ciba Geigy Ag Lackzusammensetzungen
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
KR100550749B1 (ko) 2000-03-17 2006-02-08 히사미쓰 세이야꾸 가부시키가이샤 자외선 차폐성의 첩부제
NZ541807A (en) * 2003-02-21 2009-07-31 Bayer Schering Pharma Ag UV stable transdermal therapeutic plaster
EP1452173A1 (de) * 2003-02-25 2004-09-01 Schering AG UV-stabiles transdermales Pflaster
RU2354664C2 (ru) * 2003-09-11 2009-05-10 Циба Спешиалти Кемикэлз Холдинг Инк. Концентрированные формы светостабилизаторов на водной основе, полученные по методике гетерофазной полимеризации

Also Published As

Publication number Publication date
JP2013177451A (ja) 2013-09-09
KR101351161B1 (ko) 2014-01-14
SI1879560T1 (sl) 2015-01-30
KR20080003854A (ko) 2008-01-08
CN108969507A (zh) 2018-12-11
AR055927A1 (es) 2007-09-12
GT200600183A (es) 2007-01-03
KR20130099203A (ko) 2013-09-05
JP2008540352A (ja) 2008-11-20
IL186945A0 (en) 2008-02-09
EP1879560B1 (de) 2014-08-27
UY29511A1 (es) 2006-08-31
CA2605112C (en) 2013-11-05
PE20061414A1 (es) 2007-01-26
CN101171001A (zh) 2008-04-30
DK1879560T3 (en) 2014-11-24
ES2523663T3 (es) 2014-11-28
EP1879560A2 (de) 2008-01-23
WO2006117139A2 (de) 2006-11-09
ZA200710418B (en) 2009-08-26
AU2006243442A1 (en) 2006-11-09
EP1719504A1 (de) 2006-11-08
PT1879560E (pt) 2014-11-19
BRPI0611087A2 (pt) 2010-08-03
CY1115757T1 (el) 2017-01-25
WO2006117139A3 (de) 2007-04-19
JP5360877B2 (ja) 2013-12-04
TW200719902A (en) 2007-06-01
EA200702344A1 (ru) 2008-12-30
KR101426218B1 (ko) 2014-08-05
DOP2006000100A (es) 2007-01-31
CA2605112A1 (en) 2006-11-09
MX2007013779A (es) 2008-01-22
PL1879560T3 (pl) 2015-02-27
NO20076187L (no) 2007-11-30

Similar Documents

Publication Publication Date Title
UY28189A1 (es) Sistema terapéutico transdérmico estable a los rayos uv.
GT200800075A (es) Sistema terapeutico transdermico
ECSP088220A (es) Uso de dosis única de moléculas de unión específica cd20
AR070031A1 (es) Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas
ECSP055953A (es) Granisetron transdermico
AR067600A1 (es) Pelicula de material compuesto polimerico con funcion de barrera
MX2007004342A (es) Moleculas cop1 y uso de las mismas.
EA200400866A1 (ru) Ламинированный инсектицидный диспенсер
AR058177A1 (es) Composiciones para el tratamiento del cabello
PE20070312A1 (es) Estuche para alojar un envase con medicamento
GT200500246A (es) Combinacion de compuestos organicos
CL2004001426A1 (es) Procedimiento para preparar atorvastatina amorfa que comprende disolver atorvastatina en una solucion que incluye un solvente hidroxilico y evaporar rapidamente dicho solvente desde la solucion; composicion farmaceutica que la contiene, util en el tr
TW200643064A (en) Transparent film and method for manufacturing the same, polarized plate and image display device
CU24431B1 (es) Sistema para la administración de fármacos
UY29511A1 (es) Sistema terapéutico transdérmico sólido con absorbedor uv
CL2008000683A1 (es) Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de la enzima de conversion de angiotensina (ace); formulacion de dosis unitaria; y uso en el tratamiento de la diabetes.
DE60306379D1 (de) Diffusionskontrolliertes wirkstoffabgabesystem mit fluorosiloxan-matrix
AR028525A1 (es) Sistema terapeutico transdermal para la administracion de lerisetron
AR105791A2 (es) Método para el tratamiento de biomasa
AR054012A1 (es) Sistema terapeutico transdermico para la adminstracion de analgesicos
MX2014003865A (es) Sistema de desecho de parche transdermico.
CL2008000185A1 (es) Dispositivo de abrazadera para sistema de pavimento poroso portatil que comprende una primera placa de soporte de seccion u y una segunda placa de soporte de seccion c, la primera placa teniendo dos aletas que definen dos ranuras y la segunda placa p
BRPI0520821A2 (pt) formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada
CL2007003603A1 (es) Elemento multilaminar conformado tridimensionalmente que comprende una pelicula de soporte al menos parcialmente transparente, constituida por al menos un material laminar estirable en frio, al menos un elemento electroluminiscente, un electrodo al menos parcialmente transparente; y procedimiento para fabricar un elemento multilaminar.
CR8461A (es) Forma de administracion transdermica, liquida o semisolida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)